These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

146 related items for PubMed ID: 39046197

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Risk factors for acute kidney injury in patients treated with polymyxin B or colistin methanesulfonate sodium.
    Tuon FF, Rigatto MH, Lopes CK, Kamei LK, Rocha JL, Zavascki AP.
    Int J Antimicrob Agents; 2014 Apr; 43(4):349-52. PubMed ID: 24439066
    [Abstract] [Full Text] [Related]

  • 3. Higher incidence of acute kidney injury with intravenous colistimethate sodium compared with polymyxin B in critically ill patients at a tertiary care medical center.
    Akajagbor DS, Wilson SL, Shere-Wolfe KD, Dakum P, Charurat ME, Gilliam BL.
    Clin Infect Dis; 2013 Nov; 57(9):1300-3. PubMed ID: 23840000
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Acute kidney injury associated with colistin sulfate vs. polymyxin B sulfate therapy: A real-world, retrospective cohort study.
    Zhang Y, Dong R, Huang Y, Ling X, Ye Z, Jiang S.
    Int J Antimicrob Agents; 2024 Jan; 63(1):107031. PubMed ID: 37951480
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for acute kidney injury in critically ill patients receiving high intravenous doses of colistin methanesulfonate and/or other nephrotoxic antibiotics: a retrospective cohort study.
    Rocco M, Montini L, Alessandri E, Venditti M, Laderchi A, De Pascale G, Raponi G, Vitale M, Pietropaoli P, Antonelli M.
    Crit Care; 2013 Aug 14; 17(4):R174. PubMed ID: 23945197
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Risk factors for acute kidney injury (AKI) in patients treated with polymyxin B and influence of AKI on mortality: a multicentre prospective cohort study.
    Rigatto MH, Behle TF, Falci DR, Freitas T, Lopes NT, Nunes M, Costa LW, Zavascki AP.
    J Antimicrob Chemother; 2015 May 14; 70(5):1552-7. PubMed ID: 25604744
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Nephrotoxicity prevalence in patients treated with polymyxins: a systematic review with meta-analysis of observational studies.
    Oliota AF, Penteado ST, Tonin FS, Fernandez-Llimos F, Sanches AC.
    Diagn Microbiol Infect Dis; 2019 May 14; 94(1):41-49. PubMed ID: 30635223
    [Abstract] [Full Text] [Related]

  • 13. Comparative study of polymyxin B and colistin sulfate in the treatment of severe comorbid patients infected with CR-GNB.
    Wang J, Shah BK, Zhao J, Xiong J, Wang C, Xie S.
    BMC Infect Dis; 2023 May 25; 23(1):351. PubMed ID: 37231342
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparisons of adverse event reporting for colistin versus polymyxin B using the US Food and Drug Administration Adverse Event Reporting System (FAERS).
    Truong CB, Durham SH, Qian J.
    Expert Opin Drug Saf; 2021 May 25; 20(5):603-609. PubMed ID: 33573405
    [Abstract] [Full Text] [Related]

  • 16. In vitro assessment and multicenter cohort study of comparative nephrotoxicity rates associated with colistimethate versus polymyxin B therapy.
    Phe K, Lee Y, McDaneld PM, Prasad N, Yin T, Figueroa DA, Musick WL, Cottreau JM, Hu M, Tam VH.
    Antimicrob Agents Chemother; 2014 May 25; 58(5):2740-6. PubMed ID: 24566187
    [Abstract] [Full Text] [Related]

  • 17. Polymyxin B and colistin-the economic burden of nephrotoxicity against multidrug resistant bacteria.
    Tuon FF, Rocha JL, Gasparetto J.
    J Med Econ; 2019 Feb 25; 22(2):158-162. PubMed ID: 30466325
    [Abstract] [Full Text] [Related]

  • 18. Multicenter Prospective Cohort Study of Renal Failure in Patients Treated with Colistin versus Polymyxin B.
    Rigatto MH, Oliveira MS, Perdigão-Neto LV, Levin AS, Carrilho CM, Tanita MT, Tuon FF, Cardoso DE, Lopes NT, Falci DR, Zavascki AP.
    Antimicrob Agents Chemother; 2016 Apr 25; 60(4):2443-9. PubMed ID: 26856846
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.